Benzinga | Aug 4, 2021 04:56PM EDT

Evolent Health Q2 EPS $(0.02) Beats $(0.04) Estimate, Sales $222.06M Beat $216.92M Estimate

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 33.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $222.06 million which beat the analyst consensus estimate of $216.92 million by 2.37 percent. This is a 6.95 percent decrease over sales of $238.63 million the same period last year.